Centessa Pharmaceuticals

CNTA · NASDAQ

Price unavailable right now.

No price history for this range.

Latest news

  • Press releaseGlobe Newswire

    Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales

  • News

    7 Health Care Stocks With Whale Alerts In Today's Session

  • Press releasePRNewswire

    Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

  • Press releasePRNewswire

    Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?

  • Press releasePRNewswire

    Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?

  • Press releasePRNewswire

    $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA

  • Press releaseBusiness Wire

    Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

  • Press releasePRNewswire

    Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders?

  • Press releasePRNewswire

    Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

  • Press releasePRNewswire

    SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS

  • Press releasePRNewswire

    Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders?

  • NewsCaroline Ryan

    Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy

  • Press releasePRNewswire

    SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)

  • Press releaseBusiness Wire

    Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA

  • NewsPiero Cingari

    Trump Signals Iran Exit, S&P 500 Heads For Worst Month Since September 2022: What's Moving The Market On Tuesday?

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook

  • Press releasePRNewswire

    Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders

  • Press releasePRNewswire

    Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?

  • NewsVandana Singh

    Eli Lilly Expands Into Sleep Medicine With Centessa Buyout

  • NewsAvi Kapoor

    Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

  • Press releaseBusiness Wire

    CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    Eli Lilly To Acquire Centessa Pharmaceuticals For $38.00 In Cash Per Share Plus One Non-Transferrable Contingent Value Right

  • Press releasePRNewswire

    Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

  • Press releaseGlobe Newswire

    Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting

  • NewsAvi Kapoor

    5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

  • Press releaseGlobe Newswire

    Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications

  • Press releaseGlobe Newswire

    Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

  • NewsAvi Kapoor

    This Domino's Pizza Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

  • Press releaseGlobe Newswire

    Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025

  • NewsAvi Kapoor

    This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

  • NewsAvi Kapoor

    AeroVironment Posts Downbeat Results, Joins Box, CrowdStrike And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • NewsAvi Kapoor

    Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

  • NewsVandana Singh

    Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteers

  • NewsAvi Kapoor

    Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday

  • News

    Market-Moving News for September 10th

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.